What is HPV

[unable to retrieve full-text content] 2YH: How the HPV vaccine can save your life    WCBD News 2

The global genital warts treatment market is estimated to be valued at  US$ 1,628.9 million  in  2023  and is expected to exhibit a  CAGR  of  4.7%  over the forecast period  (2023-2030). Coherent Market Insights Published Most recent Genital Warts Treatment Market Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends, and forecast. This report on the study considers important factors such as an analysis of the market, a definition of the market, market segmentation, significant trends in the industry, an examination of the competitive landscape, and research methodology. For achieving incredible growth in business, this Genital Warts Treatment market research report plays a very central role. With the particular base year and the historic year, certain estimations and calculations are performed in this Genital Warts Treatment report. Genital warts allude...

Content Archive nejmJW_1L_RGB-b LOADING

MONROE, La. (KNOE) - January is cervical cancer awareness month and the Louisiana Department of Health says death rates from cervical cancer are higher in Northeast Louisiana than in other parts of the country. According to the LDH, only 23 percent of children under thirteen have completed the Human Papillomavirus (HPV) vaccine in the Monroe region, and around 23 percent have started it but have not completed it. "So those are very low numbers and they aren't the lowest among the regions, but these are children if they're vaccinated, boys or girls will never get cervical cancer, or papillomas, all kinds of things, genital warts, it's really a good thing to do," said Region 6 Medical Director, Dr. David Holcombe. Holcombe said cervical cancer is one of the only preventable cancers through vaccination, but a lot of children under thirteen haven't gotten the vaccine. "You have a lot of people who don't see any interest, there's also a fair amount of ...

Cervical Cancer: A Preventable Death Human papillomavirus (HPV) is common virus that affects everyone. In fact, the virus is so common, about 8 out of 10 people will get it at some point in their lives. It can cause six types of cancer, including cervical, vaginal, vulvar, anal, penile, and oral/throat cancers. Some who become infected may never know it, but other infections will turn into cancer. According to the World Health Organization (WHO), cervical cancer is the fourth most common cancer among women globally, with an estimated 604,000 new cases and 342,000 deaths in 2020. The American Cancer Society estimates there will be 14,100 new cases of invasive cervical cancer diagnosed and 4,280 women will die from cervical cancer in the United States in 2022. At this point, you may be wondering "how does HPV...

Massachusetts' Department of Public Health announced that two residents were recently diagnosed with a novel strain of gonorrhea that's less responsive to medications. Gonorrhea is the second most common sexually-transmitted infection (STI) in the U.S . Cases of STIs , including gonorrhea, surged during the pandemic. There's a new strain of gonorrhea circulating in the United States that's more resistant to antibiotics. Massachusetts' Department of Public Health (DPH) announced last week that two residents were recently diagnosed with a novel strain of gonorrhea that's less responsive to the medications commonly used to treat the disease. A case involving a similar strain was also recently detected in Nevada. Both cases in Massachusetts were successfully treated with ceftriaxone — the current go-to medication for gonorrhea. According to the DPH, this is the first time that a gonorrhea strain has appeared resistant to five classes of antibiotics in the United St...

Topline The Massachusetts Department of Public Health announced on Thursday two cases of a novel strain of gonorrhea—one which is resistant to five classes of antibiotic treatment, and which health officials have warned about for years—were found in Massachusetts. Key Facts The patients—who the MDPH have yet to find a connection between—were ultimately treated and cured with ceftriaxone, the only antibiotic recommended to treat gonorrhea, according to the Centers for Disease Control and Prevention. Gonorrhea can easily develop a resistance to antibiotics, and almost half of the infections reported in 2020 were estimated to have been resistant to at least one form of antibiotic—the CDC named gonorrhea one of the three most urgent threats posed by antibiotic-resistant bacteria in 2013. Gentamicin was the only drug tested against the Massachusetts strain the bacteria wasn't resistant toward, but the antibiotic is generally believed to be...